AXVS 101

product on 1 show · 1 statements across 1 episodes

the a16z Podcast

1 statements about AXVS 101, every show

a16z Assertion Supported
Hirasaki: AveXis acquisition gave Novartis an AAV9 platform for gene delivery
“So the lead asset AXVS- one-on-one it, you know, certainly is going to be probably best in class for SMA, but it also gave Novartis an AAV nine vector platform that it could use to deliver other gene therapies.”
Koki Hirasaki Feb 28, 2019 ▶ 5:36 What’s with All the Bio M&A in 2019?: A Quick Take

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.